CClinicalTrials.gg
WithdrawnNCT03934996Updated Jun 21, 2024

Quality and Behavior of Pelvic Floor in Runner Women

An interventional study of Runners with educational training in Pelvic Floor Disorders, Sport Injury and Stress Urinary Incontinence, sponsored by University of Malaga. Withdrawn at 1 site in Spain. Open to female participants aged 25 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-21.

Sponsored by University of Malaga · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Stopped PhD project
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
25 Years to 44 Years
Sex
Female
01

Study summary

The main objective is to analyze the relationship between the PF muscles and the other variables along the different tasks of daily life and during the race.

Read the detailed description

Introduction: Women are more likely to suffer injuries in the Pelvic Floor (PF) and Urinary Incontinence (UI) because of their anatomical characteristics. Their participation in the sports field has been more active recently. There are studies that correlate the race with presenting weakness of the SP muscles and Stress Urinary Incontinence (SUI), so the race is considers as a risk factor for these affectations. However, there are few studies of real-time measurements during running. Some runners may even present SUI during daily activities (ADL). The UI is not only a physical problem but also affects the social, emotional, psychological, sexual and professional level and may even lower their self-esteem or renounce the physical activity.

Objectives: The purpose of this study is to perform measurements of different variables in real time while running and in their ADL. The main objective is to analyze the relationship between the PF muscles and the other variables along the different tasks of daily life and during the race. The secondary objectives are to differentiate these neuromuscular, physiological and biomechanical responses of PF and abdominal girdle (AG) according to the type of stroke, duration, intensity and distance. And compare results between both group (interventional group and no interventional group).

Material and method: Randomized clinical trial will be performed with 59 female runners aged 25-44 years. The sample will be divided into two groups randomly. The study will be carried out health center called "Tiro de Pichón" in Málaga.

02

Conditions studied

  • Pelvic Floor Disorders
  • Sport Injury
  • Stress Urinary Incontinence

Keywords

  • pelvic floor
  • athletes
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

Browse Urinary Incontinence studies →

Lead sponsor

University of Malaga is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy woman between 25 and 44 years old.
  • Women not pregnant.
  • Women who run at least 10 km / week.
  • In case of having children, it has to be 12 months after childbirth, having had the first postpartum menstruation and having left breastfeeding.

Exclusion criteria

Exclusion Criteria:

  • Women Pregnant or suspected of it.
  • Postpartum less than one year.
  • Having the period during the exploration for the classification in groups or during the day of the measurements.
  • Present operation in the urogenital region as well as any visceral or spinal operation.
  • Urinary tract and/or vaginal infections.
  • Vaginal lesions; anorectal lesions or bleeding.
  • Women with gynecological bleeding; urethral obstruction; fistulas; malformations (ectopic ureter, etc); genital prolapse.
  • Women with pain in Pelvic Floor or lower limbs or back.
  • Pain during the race.
  • Allergy to silver, nickel and/or latex.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Assesment Runners

    Healthy woman between 25 and 44 years old, not pregnant and running at least 10 km/week.

  • Experimental
    Runners with educational training

    Healthy woman between 25 and 44 years old, not pregnant and running at least 10 km/week with educational training about pelvic floor muscles.

    Other: Runners with educational training

Interventions

  • OtherRunners with educational training

    Intervention will consist of an educational talk to know the anatomy and function of the Pelvic Floor Muscles and 20 minutes of both strength and endurance exercises with biofeedback. An exercise protocol will be carried out. The participants will be instruct to contract and maintain maximum force for a mean period of 6 seconds (endurance training) and rest for twice the length of the endurance training time, followed by three fast contractions in a row as strength training. It will be done twice a week, during 12 weeks. Pelvic floor assesment: Perineometry, manual palpation, electromyography Trunk and lower limbs electromyography and kinematics

06

What researchers measure

Primary outcomes

  1. Change %MVC

    Change % of Maximun voluntary contraction

    Time frame: Prior and after intervention, an average of 12 weeks

  2. Change of Base Tone of Pelvic Floor Muscles (EMG)

    Electromyography of base tone of Pelvic Floor Muscles

    Time frame: baseline, prior and after intervention, an average of 12 weeks

  3. Change of step length

    Metres of the step length. It will measure with two cinematic shimmers wich will be placed on both tibias.

    Time frame: Prior and after intervention, an average of 12 weeks

  4. Change of cadence

    steps/secons. It will measure with two cinematic shimmers wich will be placed on both tibias.It will measure with a cinematic shimmer wich will be placed on both tibias.

    Time frame: Prior and after intervention, an average of 12 weeks

  5. Change of ground reaction force

    Newton of the ground reaction force. It will measure with two cinematic shimmers wich will be placed on both tibias.

    Time frame: Prior and after intervention, an average of 12 weeks

  6. Change of acceleration

    Change of Acceleration (m/s2 axes X, Y, Z). It will measure with a EXG shimmer wich will be placed on the sternun.

    Time frame: Prior and after intervention, an average of 12 weeks

  7. Change of displacement

    metres of displacement. It will measure with two cinematic shimmers wich will be placed on both tibias.

    Time frame: Prior and after intervention, an average of 12 weeks

  8. Change of accumulated fatigue

    Using Lactate Pro 2. Mmol/Litres

    Time frame: Prior and after intervention, an average of 12 weeks

  9. Change of heart rate

    Heart Rate

    Time frame: Prior and after intervention, an average 12 weeks

  10. Perineometry of MCV

    perineometry of MCV using PFX

    Time frame: baseline, prior and after intervention, an average of 12 weeks

  11. Intravaginal manual palpation

    manual testing of the levator ani muscles using scale of Daniels

    Time frame: baseline, prior and after intervention, an average of 12 weeks

  12. Change of electromyography of Pelvic Floor Muscles

    Change of electromyography of Pelvic Floor Muscles

    Time frame: Prior and after intervention, an average of 12 weeks

Secondary outcomes

  1. Change Pelvic floor functional capacity

    Difference between Perineometry of MCV and Base Tone of Pelvic Floor Muscles (EMG)

    Time frame: Prior and after intervention, an average of 12 weeks

  2. Quality of life score

    Using SF-12 health survey scoring demonstration. It provides a profile of the state of health and is one of the most commonly used generic scales in the evaluation of clinical outcomes. It is a self-administered instrument of 12 items from the 8 dimensions of the SF-36: Physical Function (2), Social Function (1), Physical Role (2), Emotional Role (2), Mental Health (2), Vitality (1) ), Corporal Pain (1), General Health (1). For each of the 8 dimensions, the items are coded, aggregated and transformed into a scale that ranges from 0 (the worst state of health for that dimension) to 100 (the best state of health). Validated by Ware J Jr, Kosinki M, Meller SD. and the Spanish version by Vilagut et al., 2008, who obtained an internal consistency coefficient of about 0.9 for Sf-36 and lower light for SF-12. The Cronbach alpha coefficients of the summary components of the SF-12 exceeded the proposed minimum of 0.7 for group comparisons.

    Time frame: Prior and after intervention, an average of 12 weeks

07

Study locations

1 site
  • University of Malaga
    Malaga, 29009, Spain
08

References and documents

Publications

  • Hagovska M, Svihra J, Bukova A, Horbacz A, Drackova D, Svihrova V, Kraus L. Prevalence of Urinary Incontinence in Females Performing High-Impact Exercises. Int J Sports Med. 2017 Mar;38(3):210-216. doi: 10.1055/s-0042-123045. Epub 2017 Feb 17. Erratum In: Int J Sports Med. 2017 Mar;38(3):e1. doi: 10.1055/s-0043-120578. PubMed 28212587 ↗
  • Chevalier F, Fernandez-Lao C, Cuesta-Vargas AI. Normal reference values of strength in pelvic floor muscle of women: a descriptive and inferential study. BMC Womens Health. 2014 Nov 25;14:143. doi: 10.1186/s12905-014-0143-4. PubMed 25420756 ↗
  • Leitner M, Moser H, Eichelberger P, Kuhn A, Radlinger L. Evaluation of pelvic floor muscle activity during running in continent and incontinent women: An exploratory study. Neurourol Urodyn. 2017 Aug;36(6):1570-1576. doi: 10.1002/nau.23151. Epub 2016 Oct 29. PubMed 27794169 ↗
  • Luginbuehl H, Naeff R, Zahnd A, Baeyens JP, Kuhn A, Radlinger L. Pelvic floor muscle electromyography during different running speeds: an exploratory and reliability study. Arch Gynecol Obstet. 2016 Jan;293(1):117-124. doi: 10.1007/s00404-015-3816-9. Epub 2015 Jul 21. PubMed 26193953 ↗
  • Goldstick O, Constantini N. Urinary incontinence in physically active women and female athletes. Br J Sports Med. 2014 Feb;48(4):296-8. doi: 10.1136/bjsports-2012-091880. Epub 2013 May 18. PubMed 23687004 ↗
  • Bo K. Urinary incontinence, pelvic floor dysfunction, exercise and sport. Sports Med. 2004;34(7):451-64. doi: 10.2165/00007256-200434070-00004. PubMed 15233598 ↗
  • Carvalhais A, Da Roza T, Vilela S, Jorge RN, Bo K. Association Between Physical Activity Level and Pelvic Floor Muscle Variables in Women. Int J Sports Med. 2018 Dec;39(13):995-1000. doi: 10.1055/a-0596-7531. Epub 2018 Oct 16. PubMed 30326528 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03934996
Lead sponsor
University of Malaga
Responsible party
Dr. Antonio I Cuesta-Vargas (Principal Researcher of CTS631 University of Malaga, University of Malaga) — Principal investigator
First posted
May 2, 2019
Start date
Jun 1, 2021 (estimated)
Primary completion
Jul 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jun 21, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion